Citation Tools

Download PDFPDF
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma

Download to a citation manager

Cite this article as:
Valerio MR, Tagliaferri P, Raspagliesi F, et al
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma